nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivaroxaban—ABCB1—Methylprednisolone—psoriatic arthritis	0.121	0.152	CbGbCtD
Rivaroxaban—ABCB1—Betamethasone—psoriatic arthritis	0.0788	0.0988	CbGbCtD
Rivaroxaban—ABCB1—Prednisolone—psoriatic arthritis	0.0778	0.0975	CbGbCtD
Rivaroxaban—ABCB1—Prednisone—psoriatic arthritis	0.0734	0.0921	CbGbCtD
Rivaroxaban—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0726	0.0911	CbGbCtD
Rivaroxaban—CYP3A5—Dexamethasone—psoriatic arthritis	0.0704	0.0883	CbGbCtD
Rivaroxaban—CYP3A4—Triamcinolone—psoriatic arthritis	0.055	0.069	CbGbCtD
Rivaroxaban—CYP3A4—Betamethasone—psoriatic arthritis	0.0472	0.0592	CbGbCtD
Rivaroxaban—CYP3A4—Prednisolone—psoriatic arthritis	0.0466	0.0584	CbGbCtD
Rivaroxaban—ABCB1—Dexamethasone—psoriatic arthritis	0.0458	0.0575	CbGbCtD
Rivaroxaban—CYP3A4—Prednisone—psoriatic arthritis	0.044	0.0552	CbGbCtD
Rivaroxaban—ABCB1—Methotrexate—psoriatic arthritis	0.0368	0.0462	CbGbCtD
Rivaroxaban—CYP3A4—Dexamethasone—psoriatic arthritis	0.0275	0.0344	CbGbCtD
Rivaroxaban—Infestation—Methylprednisolone—psoriatic arthritis	0.000779	0.00384	CcSEcCtD
Rivaroxaban—Infestation NOS—Methylprednisolone—psoriatic arthritis	0.000779	0.00384	CcSEcCtD
Rivaroxaban—Haemoglobin—Prednisolone—psoriatic arthritis	0.000766	0.00378	CcSEcCtD
Rivaroxaban—Haemorrhage—Prednisolone—psoriatic arthritis	0.000762	0.00376	CcSEcCtD
Rivaroxaban—Epistaxis—Triamcinolone—psoriatic arthritis	0.000736	0.00363	CcSEcCtD
Rivaroxaban—Renal failure acute—Methotrexate—psoriatic arthritis	0.000725	0.00358	CcSEcCtD
Rivaroxaban—Haemoglobin—Triamcinolone—psoriatic arthritis	0.000704	0.00348	CcSEcCtD
Rivaroxaban—Haemoglobin—Methylprednisolone—psoriatic arthritis	0.000703	0.00347	CcSEcCtD
Rivaroxaban—Haemorrhage—Triamcinolone—psoriatic arthritis	0.000701	0.00346	CcSEcCtD
Rivaroxaban—Haemorrhage—Methylprednisolone—psoriatic arthritis	0.000699	0.00345	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.000687	0.00339	CcSEcCtD
Rivaroxaban—Osteoarthritis—Methotrexate—psoriatic arthritis	0.000669	0.0033	CcSEcCtD
Rivaroxaban—Eye disorder—Methylprednisolone—psoriatic arthritis	0.000653	0.00322	CcSEcCtD
Rivaroxaban—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.000649	0.0032	CcSEcCtD
Rivaroxaban—Haemoglobin—Dexamethasone—psoriatic arthritis	0.000639	0.00315	CcSEcCtD
Rivaroxaban—Haemoglobin—Betamethasone—psoriatic arthritis	0.000639	0.00315	CcSEcCtD
Rivaroxaban—Haemorrhage—Dexamethasone—psoriatic arthritis	0.000636	0.00314	CcSEcCtD
Rivaroxaban—Haemorrhage—Betamethasone—psoriatic arthritis	0.000636	0.00314	CcSEcCtD
Rivaroxaban—Angiopathy—Methylprednisolone—psoriatic arthritis	0.000634	0.00313	CcSEcCtD
Rivaroxaban—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.000632	0.00312	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.00063	0.00311	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.000616	0.00304	CcSEcCtD
Rivaroxaban—Angioedema—Prednisolone—psoriatic arthritis	0.000606	0.00299	CcSEcCtD
Rivaroxaban—Malaise—Prednisolone—psoriatic arthritis	0.000598	0.00295	CcSEcCtD
Rivaroxaban—Syncope—Prednisolone—psoriatic arthritis	0.000595	0.00294	CcSEcCtD
Rivaroxaban—Eye disorder—Betamethasone—psoriatic arthritis	0.000594	0.00293	CcSEcCtD
Rivaroxaban—Eye disorder—Dexamethasone—psoriatic arthritis	0.000594	0.00293	CcSEcCtD
Rivaroxaban—Back pain—Triamcinolone—psoriatic arthritis	0.00059	0.00291	CcSEcCtD
Rivaroxaban—Loss of consciousness—Prednisolone—psoriatic arthritis	0.000583	0.00288	CcSEcCtD
Rivaroxaban—Angiopathy—Dexamethasone—psoriatic arthritis	0.000577	0.00285	CcSEcCtD
Rivaroxaban—Angiopathy—Betamethasone—psoriatic arthritis	0.000577	0.00285	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.000566	0.00279	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.000565	0.00279	CcSEcCtD
Rivaroxaban—Discomfort—Prednisolone—psoriatic arthritis	0.000558	0.00275	CcSEcCtD
Rivaroxaban—Angioedema—Triamcinolone—psoriatic arthritis	0.000557	0.00275	CcSEcCtD
Rivaroxaban—Haemoglobin—Prednisone—psoriatic arthritis	0.000557	0.00275	CcSEcCtD
Rivaroxaban—Angioedema—Methylprednisolone—psoriatic arthritis	0.000556	0.00274	CcSEcCtD
Rivaroxaban—Haemorrhage—Prednisone—psoriatic arthritis	0.000554	0.00273	CcSEcCtD
Rivaroxaban—Malaise—Triamcinolone—psoriatic arthritis	0.00055	0.00271	CcSEcCtD
Rivaroxaban—Malaise—Methylprednisolone—psoriatic arthritis	0.000549	0.00271	CcSEcCtD
Rivaroxaban—Syncope—Triamcinolone—psoriatic arthritis	0.000547	0.0027	CcSEcCtD
Rivaroxaban—Syncope—Methylprednisolone—psoriatic arthritis	0.000546	0.00269	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000544	0.00269	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000541	0.00267	CcSEcCtD
Rivaroxaban—Oedema—Prednisolone—psoriatic arthritis	0.000541	0.00267	CcSEcCtD
Rivaroxaban—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000536	0.00265	CcSEcCtD
Rivaroxaban—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000535	0.00264	CcSEcCtD
Rivaroxaban—Shock—Prednisolone—psoriatic arthritis	0.000533	0.00263	CcSEcCtD
Rivaroxaban—Tachycardia—Prednisolone—psoriatic arthritis	0.000528	0.00261	CcSEcCtD
Rivaroxaban—Eye disorder—Prednisone—psoriatic arthritis	0.000518	0.00255	CcSEcCtD
Rivaroxaban—Infestation NOS—Methotrexate—psoriatic arthritis	0.000516	0.00254	CcSEcCtD
Rivaroxaban—Infestation—Methotrexate—psoriatic arthritis	0.000516	0.00254	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000515	0.00254	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000514	0.00253	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000514	0.00253	CcSEcCtD
Rivaroxaban—Discomfort—Triamcinolone—psoriatic arthritis	0.000513	0.00253	CcSEcCtD
Rivaroxaban—Discomfort—Methylprednisolone—psoriatic arthritis	0.000512	0.00253	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.000511	0.00252	CcSEcCtD
Rivaroxaban—Dry mouth—Triamcinolone—psoriatic arthritis	0.000508	0.00251	CcSEcCtD
Rivaroxaban—Renal failure—Methotrexate—psoriatic arthritis	0.000507	0.0025	CcSEcCtD
Rivaroxaban—Angioedema—Betamethasone—psoriatic arthritis	0.000506	0.0025	CcSEcCtD
Rivaroxaban—Angioedema—Dexamethasone—psoriatic arthritis	0.000506	0.0025	CcSEcCtD
Rivaroxaban—Angiopathy—Prednisone—psoriatic arthritis	0.000502	0.00248	CcSEcCtD
Rivaroxaban—Immune system disorder—Prednisone—psoriatic arthritis	0.0005	0.00247	CcSEcCtD
Rivaroxaban—Malaise—Betamethasone—psoriatic arthritis	0.000499	0.00246	CcSEcCtD
Rivaroxaban—Malaise—Dexamethasone—psoriatic arthritis	0.000499	0.00246	CcSEcCtD
Rivaroxaban—Oedema—Triamcinolone—psoriatic arthritis	0.000498	0.00246	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000498	0.00246	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000497	0.00245	CcSEcCtD
Rivaroxaban—Syncope—Dexamethasone—psoriatic arthritis	0.000496	0.00245	CcSEcCtD
Rivaroxaban—Syncope—Betamethasone—psoriatic arthritis	0.000496	0.00245	CcSEcCtD
Rivaroxaban—Infection—Triamcinolone—psoriatic arthritis	0.000495	0.00244	CcSEcCtD
Rivaroxaban—Infection—Methylprednisolone—psoriatic arthritis	0.000494	0.00244	CcSEcCtD
Rivaroxaban—Haematuria—Methotrexate—psoriatic arthritis	0.000492	0.00243	CcSEcCtD
Rivaroxaban—Shock—Triamcinolone—psoriatic arthritis	0.00049	0.00242	CcSEcCtD
Rivaroxaban—Shock—Methylprednisolone—psoriatic arthritis	0.000489	0.00241	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000488	0.00241	CcSEcCtD
Rivaroxaban—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000487	0.0024	CcSEcCtD
Rivaroxaban—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000487	0.0024	CcSEcCtD
Rivaroxaban—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000487	0.0024	CcSEcCtD
Rivaroxaban—Epistaxis—Methotrexate—psoriatic arthritis	0.000486	0.0024	CcSEcCtD
Rivaroxaban—Tachycardia—Triamcinolone—psoriatic arthritis	0.000486	0.0024	CcSEcCtD
Rivaroxaban—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000485	0.00239	CcSEcCtD
Rivaroxaban—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000483	0.00238	CcSEcCtD
Rivaroxaban—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000481	0.00237	CcSEcCtD
Rivaroxaban—Discomfort—Dexamethasone—psoriatic arthritis	0.000466	0.0023	CcSEcCtD
Rivaroxaban—Discomfort—Betamethasone—psoriatic arthritis	0.000466	0.0023	CcSEcCtD
Rivaroxaban—Haemoglobin—Methotrexate—psoriatic arthritis	0.000465	0.0023	CcSEcCtD
Rivaroxaban—Hypotension—Methylprednisolone—psoriatic arthritis	0.000464	0.00229	CcSEcCtD
Rivaroxaban—Pain—Prednisolone—psoriatic arthritis	0.000463	0.00228	CcSEcCtD
Rivaroxaban—Haemorrhage—Methotrexate—psoriatic arthritis	0.000463	0.00228	CcSEcCtD
Rivaroxaban—Hepatitis—Methotrexate—psoriatic arthritis	0.000463	0.00228	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000457	0.00226	CcSEcCtD
Rivaroxaban—Urethral disorder—Methotrexate—psoriatic arthritis	0.000454	0.00224	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000452	0.00223	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000452	0.00223	CcSEcCtD
Rivaroxaban—Oedema—Dexamethasone—psoriatic arthritis	0.000452	0.00223	CcSEcCtD
Rivaroxaban—Oedema—Betamethasone—psoriatic arthritis	0.000452	0.00223	CcSEcCtD
Rivaroxaban—Infection—Dexamethasone—psoriatic arthritis	0.000449	0.00221	CcSEcCtD
Rivaroxaban—Infection—Betamethasone—psoriatic arthritis	0.000449	0.00221	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000447	0.00221	CcSEcCtD
Rivaroxaban—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000446	0.0022	CcSEcCtD
Rivaroxaban—Anaemia—Prednisone—psoriatic arthritis	0.000446	0.0022	CcSEcCtD
Rivaroxaban—Shock—Betamethasone—psoriatic arthritis	0.000444	0.00219	CcSEcCtD
Rivaroxaban—Shock—Dexamethasone—psoriatic arthritis	0.000444	0.00219	CcSEcCtD
Rivaroxaban—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000444	0.00219	CcSEcCtD
Rivaroxaban—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000443	0.00219	CcSEcCtD
Rivaroxaban—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000443	0.00219	CcSEcCtD
Rivaroxaban—Tachycardia—Dexamethasone—psoriatic arthritis	0.000441	0.00218	CcSEcCtD
Rivaroxaban—Tachycardia—Betamethasone—psoriatic arthritis	0.000441	0.00218	CcSEcCtD
Rivaroxaban—Angioedema—Prednisone—psoriatic arthritis	0.00044	0.00217	CcSEcCtD
Rivaroxaban—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000438	0.00216	CcSEcCtD
Rivaroxaban—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000438	0.00216	CcSEcCtD
Rivaroxaban—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000437	0.00216	CcSEcCtD
Rivaroxaban—Malaise—Prednisone—psoriatic arthritis	0.000435	0.00215	CcSEcCtD
Rivaroxaban—Eye disorder—Methotrexate—psoriatic arthritis	0.000433	0.00213	CcSEcCtD
Rivaroxaban—Syncope—Prednisone—psoriatic arthritis	0.000432	0.00213	CcSEcCtD
Rivaroxaban—Urticaria—Prednisolone—psoriatic arthritis	0.00043	0.00212	CcSEcCtD
Rivaroxaban—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00043	0.00212	CcSEcCtD
Rivaroxaban—Fatigue—Triamcinolone—psoriatic arthritis	0.000429	0.00212	CcSEcCtD
Rivaroxaban—Fatigue—Methylprednisolone—psoriatic arthritis	0.000428	0.00211	CcSEcCtD
Rivaroxaban—Pain—Triamcinolone—psoriatic arthritis	0.000426	0.0021	CcSEcCtD
Rivaroxaban—Loss of consciousness—Prednisone—psoriatic arthritis	0.000424	0.00209	CcSEcCtD
Rivaroxaban—Hypotension—Dexamethasone—psoriatic arthritis	0.000422	0.00208	CcSEcCtD
Rivaroxaban—Hypotension—Betamethasone—psoriatic arthritis	0.000422	0.00208	CcSEcCtD
Rivaroxaban—Angiopathy—Methotrexate—psoriatic arthritis	0.00042	0.00207	CcSEcCtD
Rivaroxaban—Immune system disorder—Methotrexate—psoriatic arthritis	0.000418	0.00206	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000417	0.00206	CcSEcCtD
Rivaroxaban—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00041	0.00202	CcSEcCtD
Rivaroxaban—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000409	0.00202	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000408	0.00201	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000406	0.002	CcSEcCtD
Rivaroxaban—Discomfort—Prednisone—psoriatic arthritis	0.000405	0.002	CcSEcCtD
Rivaroxaban—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000399	0.00197	CcSEcCtD
Rivaroxaban—Dyspepsia—Betamethasone—psoriatic arthritis	0.000398	0.00196	CcSEcCtD
Rivaroxaban—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000398	0.00196	CcSEcCtD
Rivaroxaban—Urticaria—Triamcinolone—psoriatic arthritis	0.000396	0.00195	CcSEcCtD
Rivaroxaban—Urticaria—Methylprednisolone—psoriatic arthritis	0.000395	0.00195	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000393	0.00194	CcSEcCtD
Rivaroxaban—Oedema—Prednisone—psoriatic arthritis	0.000393	0.00194	CcSEcCtD
Rivaroxaban—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000393	0.00194	CcSEcCtD
Rivaroxaban—Infection—Prednisone—psoriatic arthritis	0.000391	0.00193	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00039	0.00192	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00039	0.00192	CcSEcCtD
Rivaroxaban—Back pain—Methotrexate—psoriatic arthritis	0.00039	0.00192	CcSEcCtD
Rivaroxaban—Fatigue—Dexamethasone—psoriatic arthritis	0.000389	0.00192	CcSEcCtD
Rivaroxaban—Fatigue—Betamethasone—psoriatic arthritis	0.000389	0.00192	CcSEcCtD
Rivaroxaban—Shock—Prednisone—psoriatic arthritis	0.000387	0.00191	CcSEcCtD
Rivaroxaban—Pain—Dexamethasone—psoriatic arthritis	0.000386	0.00191	CcSEcCtD
Rivaroxaban—Pain—Betamethasone—psoriatic arthritis	0.000386	0.00191	CcSEcCtD
Rivaroxaban—Nervous system disorder—Prednisone—psoriatic arthritis	0.000386	0.0019	CcSEcCtD
Rivaroxaban—Tachycardia—Prednisone—psoriatic arthritis	0.000384	0.00189	CcSEcCtD
Rivaroxaban—Skin disorder—Prednisone—psoriatic arthritis	0.000382	0.00189	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000374	0.00184	CcSEcCtD
Rivaroxaban—Anaemia—Methotrexate—psoriatic arthritis	0.000372	0.00184	CcSEcCtD
Rivaroxaban—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000372	0.00184	CcSEcCtD
Rivaroxaban—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000372	0.00184	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000369	0.00182	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000369	0.00182	CcSEcCtD
Rivaroxaban—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000367	0.00181	CcSEcCtD
Rivaroxaban—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000366	0.00181	CcSEcCtD
Rivaroxaban—Malaise—Methotrexate—psoriatic arthritis	0.000363	0.00179	CcSEcCtD
Rivaroxaban—Urticaria—Dexamethasone—psoriatic arthritis	0.000359	0.00177	CcSEcCtD
Rivaroxaban—Urticaria—Betamethasone—psoriatic arthritis	0.000359	0.00177	CcSEcCtD
Rivaroxaban—Dizziness—Prednisolone—psoriatic arthritis	0.000358	0.00177	CcSEcCtD
Rivaroxaban—Asthenia—Triamcinolone—psoriatic arthritis	0.000357	0.00176	CcSEcCtD
Rivaroxaban—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000357	0.00176	CcSEcCtD
Rivaroxaban—Abdominal pain—Betamethasone—psoriatic arthritis	0.000357	0.00176	CcSEcCtD
Rivaroxaban—Asthenia—Methylprednisolone—psoriatic arthritis	0.000356	0.00176	CcSEcCtD
Rivaroxaban—Pruritus—Triamcinolone—psoriatic arthritis	0.000352	0.00174	CcSEcCtD
Rivaroxaban—Pruritus—Methylprednisolone—psoriatic arthritis	0.000351	0.00173	CcSEcCtD
Rivaroxaban—Dyspepsia—Prednisone—psoriatic arthritis	0.000346	0.00171	CcSEcCtD
Rivaroxaban—Chest pain—Methotrexate—psoriatic arthritis	0.000343	0.00169	CcSEcCtD
Rivaroxaban—Rash—Prednisolone—psoriatic arthritis	0.000341	0.00168	CcSEcCtD
Rivaroxaban—Dermatitis—Prednisolone—psoriatic arthritis	0.000341	0.00168	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000341	0.00168	CcSEcCtD
Rivaroxaban—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00034	0.00168	CcSEcCtD
Rivaroxaban—Fatigue—Prednisone—psoriatic arthritis	0.000339	0.00167	CcSEcCtD
Rivaroxaban—Headache—Prednisolone—psoriatic arthritis	0.000339	0.00167	CcSEcCtD
Rivaroxaban—Discomfort—Methotrexate—psoriatic arthritis	0.000339	0.00167	CcSEcCtD
Rivaroxaban—Constipation—Prednisone—psoriatic arthritis	0.000336	0.00166	CcSEcCtD
Rivaroxaban—Dizziness—Triamcinolone—psoriatic arthritis	0.000329	0.00162	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000329	0.00162	CcSEcCtD
Rivaroxaban—Dizziness—Methylprednisolone—psoriatic arthritis	0.000329	0.00162	CcSEcCtD
Rivaroxaban—Infection—Methotrexate—psoriatic arthritis	0.000327	0.00161	CcSEcCtD
Rivaroxaban—Feeling abnormal—Prednisone—psoriatic arthritis	0.000324	0.0016	CcSEcCtD
Rivaroxaban—Asthenia—Dexamethasone—psoriatic arthritis	0.000324	0.0016	CcSEcCtD
Rivaroxaban—Asthenia—Betamethasone—psoriatic arthritis	0.000324	0.0016	CcSEcCtD
Rivaroxaban—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000322	0.00159	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000322	0.00159	CcSEcCtD
Rivaroxaban—Nausea—Prednisolone—psoriatic arthritis	0.000322	0.00159	CcSEcCtD
Rivaroxaban—Pruritus—Dexamethasone—psoriatic arthritis	0.00032	0.00158	CcSEcCtD
Rivaroxaban—Pruritus—Betamethasone—psoriatic arthritis	0.00032	0.00158	CcSEcCtD
Rivaroxaban—Skin disorder—Methotrexate—psoriatic arthritis	0.000319	0.00158	CcSEcCtD
Rivaroxaban—Vomiting—Triamcinolone—psoriatic arthritis	0.000317	0.00156	CcSEcCtD
Rivaroxaban—Vomiting—Methylprednisolone—psoriatic arthritis	0.000316	0.00156	CcSEcCtD
Rivaroxaban—Rash—Triamcinolone—psoriatic arthritis	0.000314	0.00155	CcSEcCtD
Rivaroxaban—Dermatitis—Triamcinolone—psoriatic arthritis	0.000314	0.00155	CcSEcCtD
Rivaroxaban—Rash—Methylprednisolone—psoriatic arthritis	0.000313	0.00155	CcSEcCtD
Rivaroxaban—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000313	0.00154	CcSEcCtD
Rivaroxaban—Urticaria—Prednisone—psoriatic arthritis	0.000313	0.00154	CcSEcCtD
Rivaroxaban—Headache—Triamcinolone—psoriatic arthritis	0.000312	0.00154	CcSEcCtD
Rivaroxaban—Headache—Methylprednisolone—psoriatic arthritis	0.000311	0.00154	CcSEcCtD
Rivaroxaban—Abdominal pain—Prednisone—psoriatic arthritis	0.000311	0.00153	CcSEcCtD
Rivaroxaban—Diarrhoea—Betamethasone—psoriatic arthritis	0.000309	0.00153	CcSEcCtD
Rivaroxaban—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000309	0.00153	CcSEcCtD
Rivaroxaban—Hypotension—Methotrexate—psoriatic arthritis	0.000307	0.00152	CcSEcCtD
Rivaroxaban—Dizziness—Betamethasone—psoriatic arthritis	0.000299	0.00147	CcSEcCtD
Rivaroxaban—Dizziness—Dexamethasone—psoriatic arthritis	0.000299	0.00147	CcSEcCtD
Rivaroxaban—Nausea—Triamcinolone—psoriatic arthritis	0.000296	0.00146	CcSEcCtD
Rivaroxaban—Nausea—Methylprednisolone—psoriatic arthritis	0.000295	0.00146	CcSEcCtD
Rivaroxaban—Dyspnoea—Methotrexate—psoriatic arthritis	0.000293	0.00145	CcSEcCtD
Rivaroxaban—Hypersensitivity—Prednisone—psoriatic arthritis	0.00029	0.00143	CcSEcCtD
Rivaroxaban—Dyspepsia—Methotrexate—psoriatic arthritis	0.000289	0.00143	CcSEcCtD
Rivaroxaban—Vomiting—Betamethasone—psoriatic arthritis	0.000287	0.00142	CcSEcCtD
Rivaroxaban—Vomiting—Dexamethasone—psoriatic arthritis	0.000287	0.00142	CcSEcCtD
Rivaroxaban—Rash—Betamethasone—psoriatic arthritis	0.000285	0.00141	CcSEcCtD
Rivaroxaban—Rash—Dexamethasone—psoriatic arthritis	0.000285	0.00141	CcSEcCtD
Rivaroxaban—Dermatitis—Dexamethasone—psoriatic arthritis	0.000285	0.0014	CcSEcCtD
Rivaroxaban—Dermatitis—Betamethasone—psoriatic arthritis	0.000285	0.0014	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000284	0.0014	CcSEcCtD
Rivaroxaban—Fatigue—Methotrexate—psoriatic arthritis	0.000283	0.0014	CcSEcCtD
Rivaroxaban—Headache—Dexamethasone—psoriatic arthritis	0.000283	0.0014	CcSEcCtD
Rivaroxaban—Headache—Betamethasone—psoriatic arthritis	0.000283	0.0014	CcSEcCtD
Rivaroxaban—Asthenia—Prednisone—psoriatic arthritis	0.000282	0.00139	CcSEcCtD
Rivaroxaban—Pain—Methotrexate—psoriatic arthritis	0.000281	0.00139	CcSEcCtD
Rivaroxaban—Pruritus—Prednisone—psoriatic arthritis	0.000278	0.00137	CcSEcCtD
Rivaroxaban—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000271	0.00134	CcSEcCtD
Rivaroxaban—Diarrhoea—Prednisone—psoriatic arthritis	0.000269	0.00133	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000269	0.00133	CcSEcCtD
Rivaroxaban—Nausea—Betamethasone—psoriatic arthritis	0.000268	0.00132	CcSEcCtD
Rivaroxaban—Nausea—Dexamethasone—psoriatic arthritis	0.000268	0.00132	CcSEcCtD
Rivaroxaban—Urticaria—Methotrexate—psoriatic arthritis	0.000261	0.00129	CcSEcCtD
Rivaroxaban—Dizziness—Prednisone—psoriatic arthritis	0.00026	0.00128	CcSEcCtD
Rivaroxaban—Abdominal pain—Methotrexate—psoriatic arthritis	0.00026	0.00128	CcSEcCtD
Rivaroxaban—Vomiting—Prednisone—psoriatic arthritis	0.00025	0.00123	CcSEcCtD
Rivaroxaban—Rash—Prednisone—psoriatic arthritis	0.000248	0.00122	CcSEcCtD
Rivaroxaban—Dermatitis—Prednisone—psoriatic arthritis	0.000248	0.00122	CcSEcCtD
Rivaroxaban—Headache—Prednisone—psoriatic arthritis	0.000246	0.00122	CcSEcCtD
Rivaroxaban—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000242	0.0012	CcSEcCtD
Rivaroxaban—Asthenia—Methotrexate—psoriatic arthritis	0.000236	0.00116	CcSEcCtD
Rivaroxaban—Nausea—Prednisone—psoriatic arthritis	0.000234	0.00115	CcSEcCtD
Rivaroxaban—Pruritus—Methotrexate—psoriatic arthritis	0.000233	0.00115	CcSEcCtD
Rivaroxaban—Diarrhoea—Methotrexate—psoriatic arthritis	0.000225	0.00111	CcSEcCtD
Rivaroxaban—Dizziness—Methotrexate—psoriatic arthritis	0.000217	0.00107	CcSEcCtD
Rivaroxaban—Vomiting—Methotrexate—psoriatic arthritis	0.000209	0.00103	CcSEcCtD
Rivaroxaban—Rash—Methotrexate—psoriatic arthritis	0.000207	0.00102	CcSEcCtD
Rivaroxaban—Dermatitis—Methotrexate—psoriatic arthritis	0.000207	0.00102	CcSEcCtD
Rivaroxaban—Headache—Methotrexate—psoriatic arthritis	0.000206	0.00102	CcSEcCtD
Rivaroxaban—Nausea—Methotrexate—psoriatic arthritis	0.000195	0.000964	CcSEcCtD
